Mirae Asset Securities hosts Global Investment Conference in Mumbai
Mirae Asset Securities on Wednesday that it successfully hosted its second Invest India Global Conference in Mumbai, India, from April 22 to 23.
The event saw participation from over 200 domestic and global institutional investors and 70 major corporations, reflecting the growing scale and influence of the company's wholesale business in India.
Key investor relations meetings were held with leading firms such as the Bombay Stock Exchange, NHPC, Vedanta, Paytm, Tata Power and Adani Energy Solutions. This engagement aimed to connect global capital with India's robust growth potential.
'This conference served as a platform where global perspectives, ideas and capital intersected with India's vast opportunities,' said Manish Jain, chief strategy officer and head of wholesale business at Mirae Asset Securities India.
'We are committed to continuing our role as a bridge linking international investors with India's dynamic market.'
Over the past three years, Mirae Asset Securities India has grown its transaction volume nearly threefold through deals with around 120 domestic institutional investors.
Profits have also significantly increased, reinforcing the firm's plan to further expand its global investor base and strengthen its position as a key gateway for cross-border investment into India.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Korea Herald
30-05-2025
- Korea Herald
Time to pivot to China, India and move beyond US: Mirae Asset vice chairman
As cracks emerge in the US-centered investment landscape -- driven by geopolitical uncertainty and waning global confidence -- Mirae Asset Securities Vice Chairman Heo Sun-ho called for a strategic rebalancing toward China and India. Speaking at a global asset allocation forum hosted by Mirae Asset in Seoul on Thursday, Heo said the global financial market has relied heavily on the US as its primary growth engine over the past three years. However, with the return of President Donald Trump and the onset of a high-tariff era, he warned that the global trade order is being reshaped. 'The recent depreciation of the US dollar reflects weakening global confidence, spurred by growing nationalism and ballooning fiscal deficits,' Heo said, urging investors to pivot from a US-centric strategy and realign their portfolios with the shifting global innovation landscape. China and India, he said, represent promising alternatives. 'Innovative technology that once fueled US growth is no longer its exclusive domain,' he added, pointing to China's accelerating technological self-reliance, supported by pro-market policy shifts. He cited examples such as Chinese AI startup DeepSeek positioning itself as a challenger to OpenAI, and BYD, which in April overtook Tesla in the European electric vehicle market for the first time. Meanwhile, India is emerging as a vast consumer market, Heo said, powered by robust digital infrastructure and a rapidly expanding population. His remarks come amid a noticeable cooling of Korean retail interest in US equities following a period of record buying. As of May 26, Korean individual investors had sold a net $1.065 billion (1.46 trillion won) in US stocks -- their first net sell-off in seven months. Even longtime favorites like Tesla and Nvidia saw combined net sales of about $306 million during the week of May 19-23. Echoing the call for a diversified investment strategy, Lee Phil-sang, director and head of Asia Pacific Research at Mirae Asset Hong Kong, highlighted China's healthcare tech sector as a compelling opportunity. He cited the country's deep talent pool as a key factor driving its progress toward catching up with the more established US biopharmaceutical industry. 'China has made significant strides in new drug development over the past four years. In 2010, its output in this field was minimal, but it now ranks second globally,' Lee said. Chinese biotech firms such as Beigene, Akeso, Hansoh, and Eccogene have been expanding globally through out-licensing deals and international clinical trials. Lee said that China is also taking the lead in advanced drug modalities, including antibody-drug conjugates, targeted cancer therapies linking antibodies to toxic agents, and bispecific antibodies, designed to bind two different antigens for enhanced efficacy. Policy shifts in China are also creating a more favorable environment for foreign investors, Lee said. Whereas past periods of double-digit economic growth often led to excessive government investment and harmful oversupply, a slowing Chinese economy is now helping to differentiate true market leaders. 'China's slow growth isn't necessarily negative,' Lee said. 'It's in low-growth conditions that world-class enterprises emerge. When a leading company dominates the domestic market and expands overseas, it sets the stage for the rise of truly global champions.'
Korea Herald
28-05-2025
- Korea Herald
Mirae Asset Securities hosts Global Investment Conference in Mumbai
Mirae Asset Securities on Wednesday that it successfully hosted its second Invest India Global Conference in Mumbai, India, from April 22 to 23. The event saw participation from over 200 domestic and global institutional investors and 70 major corporations, reflecting the growing scale and influence of the company's wholesale business in India. Key investor relations meetings were held with leading firms such as the Bombay Stock Exchange, NHPC, Vedanta, Paytm, Tata Power and Adani Energy Solutions. This engagement aimed to connect global capital with India's robust growth potential. 'This conference served as a platform where global perspectives, ideas and capital intersected with India's vast opportunities,' said Manish Jain, chief strategy officer and head of wholesale business at Mirae Asset Securities India. 'We are committed to continuing our role as a bridge linking international investors with India's dynamic market.' Over the past three years, Mirae Asset Securities India has grown its transaction volume nearly threefold through deals with around 120 domestic institutional investors. Profits have also significantly increased, reinforcing the firm's plan to further expand its global investor base and strengthen its position as a key gateway for cross-border investment into India.
Korea Herald
09-04-2025
- Korea Herald
Seoul shares dip to 17-month low on Trump tariffs; won sinks to 16-yr low
South Korean stocks fell by nearly 2 percent to a 17-month low Wednesday as the Donald Trump administration's sweeping tariffs stoked fears of an intensifying trade war between the United States and China. The local currency fell sharply against the US dollar. The benchmark Korea Composite Stock Price Index fell 40.53 points, or 1.74 percent, to close at 2,293.70. It marked the lowest closing since Oct. 31, 2023, when it finished at 2,277.99. Trade volume was moderate at 692.55 million shares worth 9.17 trillion won ($6.18 billion), with losers outnumbering winners 758 to 145. Foreigners and institutions sold a net 1.01 trillion won and 70.42 billion won worth of stocks, respectively, while individuals purchased a net 939.56 billion won. The US' reciprocal tariffs, including 25 percent duties for South Korea, went into effect earlier in the day, which came on the heels of a minimum 10 percent baseline tariff that came into force on Saturday. Trump also warned of additional 50 percent tariffs on China if Beijing does not withdraw its retaliatory 34 percent tariffs against his country, stoking fears of an escalating trade war between the world's two largest economies and its impact on the trade-dependent South Korean economy. "The index could fall further as China's strong retaliatory measures are expected," Park Hee-chan, a researcher at Mirae Asset Securities, said. Losses were wide and deep across the board. Top-cap Samsung Electronics sank 0.93 percent to 53,000 won, and its chipmaking rival SK hynix tumbled 2.65 percent to 165,000 won. Major bio firm Samsung Biologics lost 1.2 percent to 992,000 won, and Celltrion nosedived 5.27 percent to 154,500 won. Leading battery maker LG Energy Solution declined 1.26 percent to 314,000 won, and No. 1 steelmaker POSCO Holdings dipped 0.8 percent to 249,500 won. Top automaker Hyundai Motor slumped 0.67 percent to 178,000 won, and its sister affiliate Kia went down 0.59 percent to 83,800 won. Leading defense equipment manufacturer Hanwha Aerospace shed 1.0 percent to 691,000 won, and top portal operator Naver decreased 1.5 percent to 176,900 won. The local currency was trading at 1,484.1 won against the greenback at 3:30 p.m., down 10.9 won from the previous session, marking the lowest level since March 2009. (Yonhap)
